Jiu Zhou Pharmaceutical (603456.SH) released its semi-annual performance report, with a net profit attributable to the parent company of 387 million yuan, a year-on-year decrease of 26.33%.

Zhuhai Jizhou Pharmaceutical (603456.SH) has released its semiannual report for the year 2026. During the reporting period, the company achieved operating revenue of 2.575 billion yuan, a year-on-year decrease of 10.3%; the net profit attributable to shareholders of the listed company was 387 million yuan, a year-on-year decrease of 26.33%; the net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 386 million yuan, a year-on-year decrease of 26.56%; basic earnings per share were 0.44 yuan. The company intends to distribute a cash dividend of 1 yuan (including tax) for every 10 shares to all shareholders.